Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease With Psychosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Early research (Phase 1)Study completedNCT00795730
What this trial is testing

Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

Who this might be right for
Alzheimer DiseaseHealthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer 24
Large-scale testing (Phase 3)Study completedNCT01862640
What this trial is testing

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Not applicableLooking for participantsNCT07509125
What this trial is testing

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

Who this might be right for
Alzheimer Dementia (AD)ALS - Amyotrophic Lateral SclerosisParkinson s Disease+7 more
Universitaire Ziekenhuizen KU Leuven 300
Testing effectiveness (Phase 2)Study completedNCT02035553
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 181
Not applicableLooking for participantsNCT06088121
What this trial is testing

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Who this might be right for
Alzheimer's DiseaseDementiaBrain Diseases+5 more
Advanced Technology & Communications 180
Large-scale testing (Phase 3)Enrolling By InvitationNCT06194799
What this trial is testing

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 752
Testing effectiveness (Phase 2)Looking for participantsNCT06887192
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 300
Early research (Phase 1)Study completedNCT02392468
What this trial is testing

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Who this might be right for
SchizophreniaAlzheimer Disease
Boehringer Ingelheim 61
Post-approval studies (Phase 4)Study completedNCT00208819
What this trial is testing

A Comparison of Two Standard Therapies in the Management of Dementia With Agitation

Who this might be right for
Senile Dementia, Alzheimer TypeDementia, Alzheimer TypeAlzheimer Disease+1 more
Emory University 50
Not applicableStudy completedNCT00015548
What this trial is testing

CATIE-Alzheimer's Disease Trial

Who this might be right for
Alzheimer's Disease
National Institute of Mental Health (NIMH) 450
Large-scale testing (Phase 3)Looking for participantsNCT05980949
What this trial is testing

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 1,000
Not applicableStudy completedNCT02192554
What this trial is testing

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

Who this might be right for
Agitation Associated With Alzheimer's DiseaseAlzheimer's TypeMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 450
Not applicableLooking for participantsNCT05847192
What this trial is testing

Tau Networks in Psychotic Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease With DelusionsAlzheimer Disease With Psychosis
Northwell Health 91
Early research (Phase 1)Ended earlyNCT01137799
What this trial is testing

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Who this might be right for
SchizophreniaAlzheimer's DiseaseCognition Disorders
Janssen Pharmaceutica N.V., Belgium 47
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Early research (Phase 1)UnknownNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Not applicableEnrolling By InvitationNCT07234851
What this trial is testing

Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.

Who this might be right for
Schizophrenia DisorderFrontotemporal Dementia, Behavioral VariantMajor Depressive Disorder (MDD)+2 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 150
Early research (Phase 1)Study completedNCT05227118
What this trial is testing

Elpipodect (MK-8189) Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 29
Large-scale testing (Phase 3)Study completedNCT00036114
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.